Peppermint Oil

Peppermint oil is the essential oil distilled from the leaves of the peppermint plant (Mentha piperita), and its principal active constituent is menthol. In a gut-health context it is not the loose oil you find in a dropper bottle for aromatherapy — it is a standardised dose of peppermint oil packaged inside a specially engineered capsule, taken as a course for irritable bowel syndrome (IBS) and other functional gut complaints. It is one of the few herbal remedies for the gut that sits on a genuinely strong clinical evidence base, repeatedly outperforming placebo in randomised trials and meta-analyses.

The single most important thing to understand about peppermint oil is the delivery form, because it is the difference between a product that helps and a product that backfires. Plain or instant-release peppermint oil dissolves in the stomach. There it relaxes the lower oesophageal sphincter — the valve that keeps stomach acid down — which causes heartburn and acid reflux, the classic complaint that puts people off peppermint oil entirely. The therapeutic target, by contrast, is the smooth muscle of the small and large intestine. So the useful product is an enteric-coated capsule (a pH-sensitive coating that stays intact through the acidic stomach and only opens further down the tract) or a modern sustained-release / triple-coated microsphere system such as IBgard that delivers the oil into the small intestine.

So the practical definition of a useful peppermint oil supplement is: a standardised peppermint oil dose in an enteric-coated or sustained-release delivery system, taken before meals as a multi-week course. A plain peppermint oil softgel with no enteric coating — or worse, drops of raw oil — is the form that causes heartburn and was not what the IBS trials tested.

Peppermint oil works as a smooth-muscle antispasmodic, and the mechanism is well characterised. Menthol, its main active, blocks calcium channels in the smooth-muscle cells that line the gut wall. Muscle contraction depends on calcium flowing into those cells; by limiting that influx, menthol relaxes the intestinal smooth muscle and damps down the exaggerated, painful spasms and cramping that drive IBS symptoms. This is the same broad category of action as prescription antispasmodic drugs, which is why peppermint oil is grouped with them in the major treatment guidelines — it is a natural antispasmodic rather than a vague 'soothing' herb. Menthol's activation of TRPM8 (a cold/menthol receptor) and a mild local anaesthetic effect on visceral nerves are thought to add to the pain relief.

This is also exactly why the enteric coating is essential rather than a nicety. The antispasmodic effect is wanted in the intestine, where the painful spasms happen. If the oil is released in the stomach, the same smooth-muscle relaxation hits the lower oesophageal sphincter instead and produces heartburn. So the coating is not just about tolerability — it routes the active to the organ where it does its job and away from the organ where it causes the side effect. Modern small-intestine-targeted formulations were engineered specifically to solve this, and a 3-year safety analysis of the IBgard delivery system reported no pattern of heartburn, in contrast to older instant-release peppermint.

The clinical payoff is consistent across the literature. Khanna 2014 (PMID 24100754) meta-analysed nine RCTs and found enteric-coated peppermint oil significantly superior to placebo for both global IBS symptom improvement and abdominal pain. Ford 2008 (PMID 19008265), the landmark BMJ review that pooled fibre, antispasmodics and peppermint oil for IBS, found peppermint oil the most effective of the three, with a number-needed-to-treat of about 2.5. Cash 2016 (PMID 26319955) — the IBSREST trial of the IBgard sustained-release system — showed a ~40% drop in total IBS symptom score in four weeks versus ~24% on placebo. Alammar 2019 (PMID 30654773) pooled the data again and confirmed a clear benefit for both global symptoms and abdominal pain, with NNTs of three and four respectively and no excess of adverse events.